title: Other complications following lipid emulsion therapy : Re: Levine M, Skolnik AB, Ruha AM, et al. (2013) Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol Dec 13. [Epub ahead of print].
authors.affiliation: Section of Medical Toxicology, Division of Emergency Medicine, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8972, Saint Louis, MO, 63110, USA, schwarze@wusm.wustl.edu.
authors.forename: Evan S
authors.initials: ES
authors.lastname: Schwarz
authors.forename: Anna M
authors.initials: AM
authors.lastname: Arroyo-Plasencia
authors.forename: Michael E
authors.initials: ME
authors.lastname: Mullins
mesh_terms: D000931:Antidotes / Q000009:adverse effects*; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology*; D008297:Male; D010195:Pancreatitis / Q000209:etiology*; D012128:Respiratory Distress Syndrome / Q000209:etiology*
chemical_list: D000931:Antidotes; D005217:Fat Emulsions, Intravenous